Literature DB >> 26207243

The anti-CD40 auto-antibody: a biomarker or a factor for the permeability of recurrent focal segmental glomerulosclerosis?

Séverine Beaudreuil1, Hans Kristian Lorenzo1, Antoine Durrbach1.   

Abstract

Entities:  

Year:  2015        PMID： 26207243      PMCID： PMC4481368          DOI： 10.3978/j.issn.2305-5839.2015.04.06

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  8 in total

1.  Successful treatment of recurrent focal segmental glomerulosclerosis with a low dose rituximab in a kidney transplant recipient.

Authors:  Jang-Hee Cho; Jong-Hak Lee; Ga-Young Park; Jeong-Hoon Lim; Jun-Seop Kim; Yoon-Jung Kang; Owen Kwon; Ji-Young Choi; Sun-Hee Park; Yong-Lim Kim; Hyung-Kee Kim; Seung Huh; Chan-Duck Kim
Journal:  Ren Fail       Date:  2014-02-06       Impact factor: 2.606

2.  A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation.

Authors:  Marianne Delville; Tara K Sigdel; Changli Wei; Jing Li; Szu-Chuan Hsieh; Alessia Fornoni; George W Burke; Patrick Bruneval; Maarten Naesens; Annette Jackson; Nada Alachkar; Guillaume Canaud; Christophe Legendre; Dany Anglicheau; Jochen Reiser; Minnie M Sarwal
Journal:  Sci Transl Med       Date:  2014-10-01       Impact factor: 17.956

3.  Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.

Authors:  Changli Wei; Shafic El Hindi; Jing Li; Alessia Fornoni; Nelson Goes; Junichiro Sageshima; Dony Maiguel; S Ananth Karumanchi; Hui-Kim Yap; Moin Saleem; Qingyin Zhang; Boris Nikolic; Abanti Chaudhuri; Pirouz Daftarian; Eduardo Salido; Armando Torres; Moro Salifu; Minnie M Sarwal; Franz Schaefer; Christian Morath; Vedat Schwenger; Martin Zeier; Vineet Gupta; David Roth; Maria Pia Rastaldi; George Burke; Phillip Ruiz; Jochen Reiser
Journal:  Nat Med       Date:  2011-07-31       Impact factor: 53.440

4.  Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population.

Authors:  J Eugen-Olsen; O Andersen; A Linneberg; S Ladelund; T W Hansen; A Langkilde; J Petersen; T Pielak; L N Møller; J Jeppesen; S Lyngbaek; M Fenger; M H Olsen; P R Hildebrandt; K Borch-Johnsen; T Jørgensen; S B Haugaard
Journal:  J Intern Med       Date:  2010-05-28       Impact factor: 8.989

5.  Antibodies to protein tyrosine phosphatase receptor type O (PTPro) increase glomerular albumin permeability (P(alb)).

Authors:  Deane S Charba; Roger C Wiggins; Meera Goyal; Bryan L Wharram; Jocelyn E Wiggins; Ellen T McCarthy; Ram Sharma; Mukut Sharma; Virginia J Savin
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-29

6.  Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome.

Authors:  J Dantal; E Bigot; W Bogers; A Testa; F Kriaa; Y Jacques; B Hurault de Ligny; P Niaudet; B Charpentier; J P Soulillou
Journal:  N Engl J Med       Date:  1994-01-06       Impact factor: 91.245

7.  Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis.

Authors:  V J Savin; R Sharma; M Sharma; E T McCarthy; S K Swan; E Ellis; H Lovell; B Warady; S Gunwar; A M Chonko; M Artero; F Vincenti
Journal:  N Engl J Med       Date:  1996-04-04       Impact factor: 91.245

8.  The focal segmental glomerulosclerosis permeability factor: biochemical characteristics and biological effects.

Authors:  Mukut Sharma; Ram Sharma; Ellen T McCarthy; Virginia J Savin
Journal:  Exp Biol Med (Maywood)       Date:  2004-01
  8 in total
  2 in total

Review 1.  Immunology of idiopathic nephrotic syndrome.

Authors:  Manuela Colucci; Giorgia Corpetti; Francesco Emma; Marina Vivarelli
Journal:  Pediatr Nephrol       Date:  2017-04-27       Impact factor: 3.714

2.  Further Evidence That the Soluble Urokinase Plasminogen Activator Receptor Does Not Directly Injure Mice or Human Podocytes.

Authors:  Efrat Harel; Jun Shoji; Vivek Abraham; Loan Miller; Zoltan G Laszik; Andrew King; Dejan Dobi; Gyula Szabo; Byron Hann; Minnie M Sarwal; Charles S Craik; Flavio Vincenti
Journal:  Transplantation       Date:  2020-01       Impact factor: 5.385
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.